• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?

作者信息

Yamanaka Kinrin, Chatterjee Nimrat, Hemann Michael T, Walker Graham C

机构信息

Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.

Koch Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.

出版信息

PLoS Genet. 2017 Aug 17;13(8):e1006842. doi: 10.1371/journal.pgen.1006842. eCollection 2017 Aug.

DOI:10.1371/journal.pgen.1006842
PMID:28817566
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5560539/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ad0/5560539/2d5b918a0395/pgen.1006842.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ad0/5560539/48460a2f153d/pgen.1006842.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ad0/5560539/43c9425d5292/pgen.1006842.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ad0/5560539/2d5b918a0395/pgen.1006842.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ad0/5560539/48460a2f153d/pgen.1006842.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ad0/5560539/43c9425d5292/pgen.1006842.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ad0/5560539/2d5b918a0395/pgen.1006842.g003.jpg

相似文献

1
Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?抑制诱变跨损伤合成：改善化疗的一种可能策略？
PLoS Genet. 2017 Aug 17;13(8):e1006842. doi: 10.1371/journal.pgen.1006842. eCollection 2017 Aug.
2
Translesion DNA Synthesis and Reinitiation of DNA Synthesis in Chemotherapy Resistance.跨损伤 DNA 合成与化疗耐药中 DNA 合成的重新起始
Biochemistry (Mosc). 2020 Aug;85(8):869-882. doi: 10.1134/S0006297920080039.
3
Inhibiting translesion DNA synthesis as an approach to combat drug resistance to DNA damaging agents.抑制跨损伤DNA合成作为对抗DNA损伤剂耐药性的一种方法。
Oncotarget. 2017 Jun 20;8(25):40804-40816. doi: 10.18632/oncotarget.17254.
4
Targeting apoptosis and DNA synthesis: understanding treatment concepts and nursing considerations.靶向细胞凋亡与DNA合成：理解治疗理念与护理要点
ONS News. 2004;19(9 Suppl):65-6.
5
Identification of Small Molecule Translesion Synthesis Inhibitors That Target the Rev1-CT/RIR Protein-Protein Interaction.靶向Rev1-CT/RIR蛋白-蛋白相互作用的小分子跨损伤合成抑制剂的鉴定
ACS Chem Biol. 2017 Jul 21;12(7):1903-1912. doi: 10.1021/acschembio.6b01144. Epub 2017 Jun 9.
6
Repair and translesion DNA polymerases as anticancer drug targets.作为抗癌药物靶点的修复和跨损伤DNA聚合酶
Anticancer Agents Med Chem. 2008 May;8(4):431-47. doi: 10.2174/187152008784220348.
7
Translesion synthesis of 1,3-GTG cisplatin DNA lesions.1,3-顺铂DNA损伤的跨损伤合成
Chembiochem. 2010 Jul 26;11(11):1521-4. doi: 10.1002/cbic.201000211.
8
Multifaceted activities of DNA polymerase η: beyond translesion DNA synthesis.DNA 聚合酶 η 的多方面活性：超越跨损伤 DNA 合成。
Curr Genet. 2019 Jun;65(3):649-656. doi: 10.1007/s00294-018-0918-5. Epub 2018 Dec 8.
9
Involvement of translesion synthesis DNA polymerases in DNA interstrand crosslink repair.跨损伤合成DNA聚合酶参与DNA链间交联修复。
DNA Repair (Amst). 2016 Aug;44:33-41. doi: 10.1016/j.dnarep.2016.05.004. Epub 2016 May 13.
10
Roles of mutagenic translesion synthesis in mammalian genome stability, health and disease.诱变跨损伤合成在哺乳动物基因组稳定性、健康和疾病中的作用。
DNA Repair (Amst). 2015 May;29:56-64. doi: 10.1016/j.dnarep.2015.01.001. Epub 2015 Jan 21.

引用本文的文献

1
Targeting hypoxia-mediated chemo-immuno resistance by a hybrid NBDHEX-Pt(IV) prodrug via declining nuclear STING1-promoted AhR-CIN in human lung squamous cell carcinoma.通过一种混合的NBDHEX-Pt(IV)前药靶向缺氧介导的化学免疫抗性，该前药可降低人肺鳞状细胞癌中细胞核STING1促进的AhR-CIN。
Transl Oncol. 2025 May;55:102350. doi: 10.1016/j.tranon.2025.102350. Epub 2025 Mar 25.
2
Catalytic and noncatalytic functions of DNA polymerase κ in translesion DNA synthesis.DNA聚合酶κ在跨损伤DNA合成中的催化和非催化功能。
Nat Struct Mol Biol. 2025 Feb;32(2):300-314. doi: 10.1038/s41594-024-01395-3. Epub 2024 Sep 19.
3
Protein Assemblies in Translesion Synthesis.

本文引用的文献

1
Identification of the first small-molecule inhibitor of the REV7 DNA repair protein interaction.REV7 DNA修复蛋白相互作用的首个小分子抑制剂的鉴定。
Bioorg Med Chem. 2016 Sep 15;24(18):4339-4346. doi: 10.1016/j.bmc.2016.07.026. Epub 2016 Jul 16.
2
DNA polymerase iota (Pol ι) promotes invasion and metastasis of esophageal squamous cell carcinoma.DNA聚合酶ι（Pol ι）促进食管鳞状细胞癌的侵袭和转移。
Oncotarget. 2016 May 31;7(22):32274-85. doi: 10.18632/oncotarget.8580.
3
Interaction between the Rev1 C-Terminal Domain and the PolD3 Subunit of Polζ Suggests a Mechanism of Polymerase Exchange upon Rev1/Polζ-Dependent Translesion Synthesis.
跨损伤合成中的蛋白质组装。
Genes (Basel). 2024 Jun 24;15(7):832. doi: 10.3390/genes15070832.
4
Lead compound profiling for small molecule inhibitors of the REV1-CT/RIR Translesion synthesis Protein-Protein interaction.先导化合物分析鉴定用于逆转录酶 REV1-CT/RIR 跨损伤合成蛋白-蛋白相互作用的小分子抑制剂。
Bioorg Med Chem. 2024 May 15;106:117755. doi: 10.1016/j.bmc.2024.117755. Epub 2024 May 9.
5
Temozolomide resistance mechanisms: unveiling the role of translesion DNA polymerase kappa in glioblastoma spheroids in vitro.替莫唑胺耐药机制：揭示跨损伤 DNA 聚合酶 κ 在体外脑胶质瘤球体中的作用。
Biosci Rep. 2024 May 29;44(5). doi: 10.1042/BSR20230667.
6
The Role of m6A-Mediated DNA Damage Repair in Tumor Development and Chemoradiotherapy Resistance.m6A介导的DNA损伤修复在肿瘤发生发展及放化疗耐药中的作用
Cancer Control. 2024 Jan-Dec;31:10732748241247170. doi: 10.1177/10732748241247170.
7
XPA tumor variant leads to defects in NER that sensitize cells to cisplatin.XPA肿瘤变体导致核苷酸切除修复缺陷，使细胞对顺铂敏感。
NAR Cancer. 2024 Mar 18;6(1):zcae013. doi: 10.1093/narcan/zcae013. eCollection 2024 Mar.
8
Chemical Insights into Oxidative and Nitrative Modifications of DNA.化学视角下的 DNA 的氧化与硝化修饰
Int J Mol Sci. 2023 Oct 16;24(20):15240. doi: 10.3390/ijms242015240.
9
SOS-independent bacterial DNA damage responses: diverse mechanisms, unifying function.不依赖 SOS 的细菌 DNA 损伤反应：多样的机制，统一的功能。
Curr Opin Microbiol. 2023 Jun;73:102323. doi: 10.1016/j.mib.2023.102323. Epub 2023 May 4.
10
Changes in metabolic landscapes shape divergent but distinct mutational signatures and cytotoxic consequences of redox stress.代谢景观的变化塑造了不同但独特的突变特征以及氧化应激的细胞毒性后果。
Nucleic Acids Res. 2023 Jun 9;51(10):5056-5072. doi: 10.1093/nar/gkad305.
Rev1 蛋白 C 末端结构域与 Polζ 聚合酶的 PolD3 亚基之间的相互作用揭示了 Rev1/Polζ 依赖性跨损伤合成过程中聚合酶交换的机制。
Biochemistry. 2016 Apr 5;55(13):2043-53. doi: 10.1021/acs.biochem.5b01282. Epub 2016 Mar 24.
4
Translesion Polymerases Drive Microhomology-Mediated Break-Induced Replication Leading to Complex Chromosomal Rearrangements.跨损伤聚合酶驱动微同源性介导的断裂诱导复制，导致复杂的染色体重排。
Mol Cell. 2015 Dec 17;60(6):860-72. doi: 10.1016/j.molcel.2015.10.041. Epub 2015 Dec 6.
5
Association of polymorphisms in translesion synthesis genes with prognosis of advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.错配修复基因多态性与铂类化疗治疗晚期非小细胞肺癌患者预后的关系。
J Surg Oncol. 2016 Jan;113(1):17-23. doi: 10.1002/jso.24103. Epub 2015 Nov 26.
6
High expression of REV7 is an independent prognostic indicator in patients with diffuse large B-cell lymphoma treated with rituximab.REV7高表达是接受利妥昔单抗治疗的弥漫性大B细胞淋巴瘤患者的独立预后指标。
Int J Hematol. 2015 Dec;102(6):662-9. doi: 10.1007/s12185-015-1880-3. Epub 2015 Oct 8.
7
REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells.REV3L调节非小细胞肺癌H1299细胞对顺铂的敏感性。
Oncol Rep. 2015 Sep;34(3):1460-8. doi: 10.3892/or.2015.4121. Epub 2015 Jul 9.
8
A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments.一项合成致死筛选鉴定出使癌细胞对联合 ATR 抑制和顺铂治疗敏感的 DNA 修复途径。
PLoS One. 2015 May 12;10(5):e0125482. doi: 10.1371/journal.pone.0125482. eCollection 2015.
9
Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells.DNA聚合酶η的表达增强有助于卵巢癌干细胞对顺铂产生耐药性。
Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):4411-6. doi: 10.1073/pnas.1421365112. Epub 2015 Mar 23.
10
REV7 counteracts DNA double-strand break resection and affects PARP inhibition.REV7可对抗DNA双链断裂切除并影响聚（ADP-核糖）聚合酶抑制作用。
Nature. 2015 May 28;521(7553):541-544. doi: 10.1038/nature14328. Epub 2015 Mar 23.